Literature DB >> 19796717

Identification of a novel dentin matrix protein-1 (DMP-1) mutation and dental anomalies in a kindred with autosomal recessive hypophosphatemia.

Serap Turan1, Cumhur Aydin, Abdullah Bereket, Teoman Akcay, Tülay Güran, Betul Akmen Yaralioglu, Murat Bastepe, Harald Jüppner.   

Abstract

An autosomal recessive form of hypophosphatemia (ARHP) was recently shown to be caused by homozygous mutations in DMP1, the gene encoding dentin matrix protein-1 (DMP-1), a non-collagenous bone matrix protein with an important role in the development and mineralization of bone and teeth. Here, we describe a previously not reported consanguineous ARHP kindred in which the three affected individuals carry a novel homozygous DMP-1 mutation. The index case presented at the age of 3 years with bowing of his legs and showed hypophosphatemia due to insufficient renal phosphate retention. Serum alkaline phosphatase activity was elevated, with initially normal PTH. FGF23 was inappropriately normal at an older age while being treated with oral phosphate and 1,25(OH)(2)D. Similar clinical and biochemical findings, except for elevated FGF23 levels, were present in his 16-month-old brother and his 12.5-year-old female cousin; the parents of the three affected children are first-degree cousins. Nucleotide sequence analysis was performed on PCR-amplified exons encoding DMP-1 and flanking intronic regions. A novel homozygous frame-shift mutation (c.485Tdel; p.Glu163ArgfsX53) in exon 6 resulting in a premature stop codon was identified in all effected individuals. The parents and available unaffected siblings were heterozygous for c.485Tdel. Tooth growth and shape were normal for the index case, his affected brother and cousin, but their permanent and deciduous teeth displayed enlarged pulp chambers. The identified genetic mutation underscores the importance of DMP-1 mutations in the pathogenesis of ARHP. Furthermore, DMP-1 mutations appear to contribute, through yet unknown mechanisms, to tooth development. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796717      PMCID: PMC2818230          DOI: 10.1016/j.bone.2009.09.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  35 in total

Review 1.  Useful measurements in the evaluation of hand radiographs.

Authors:  A K Poznanski
Journal:  Hand Clin       Date:  1991-02       Impact factor: 1.907

2.  Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype.

Authors:  Ling Ye; Yuji Mishina; Di Chen; Haiyang Huang; Sarah L Dallas; Mark R Dallas; Pitchumani Sivakumar; Tetsuo Kunieda; Takeo W Tsutsui; Adele Boskey; Lynda F Bonewald; Jian Q Feng
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

3.  Upper segment/lower segment ratio and armspan-height difference in healthy Turkish children.

Authors:  Serap Turan; Abdullah Bereket; Anjum Omar; Mustafa Berber; Ahmet Ozen; Nural Bekiroglu
Journal:  Acta Paediatr       Date:  2005-04       Impact factor: 2.299

4.  Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization.

Authors:  A George; B Sabsay; P A Simonian; A Veis
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

5.  The association of dental abscesses with vitamin D resistant rickets.

Authors:  E N Tulloch; F F Andrews
Journal:  Br Dent J       Date:  1983-03-05       Impact factor: 1.626

Review 6.  Origin, diagnosis, and treatment of the dental manifestations of vitamin D-resistant rickets: review of the literature and report of case.

Authors:  S Cohen; G L Becker
Journal:  J Am Dent Assoc       Date:  1976-01       Impact factor: 3.634

7.  Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes.

Authors:  Yves Sabbagh; Thomas O Carpenter; Marie B Demay
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

8.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium.

Authors: 
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

9.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.

Authors:  E M Eicher; J L Southard; C R Scriver; F H Glorieux
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.

Authors:  W Sullivan; T Carpenter; F Glorieux; R Travers; K Insogna
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

View more
  25 in total

Review 1.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 2.  Genetics of Refractory Rickets: Identification of Novel PHEX Mutations in Indian Patients and a Literature Update.

Authors:  Binata Marik; Arvind Bagga; Aditi Sinha; Pankaj Hari; Arundhati Sharma
Journal:  J Pediatr Genet       Date:  2018-01-28

3.  miR-145 and miR-143 regulate odontoblast differentiation through targeting Klf4 and Osx genes in a feedback loop.

Authors:  Huan Liu; Heng Lin; Li Zhang; Qin Sun; Guohua Yuan; Lu Zhang; Shuo Chen; Zhi Chen
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

Review 4.  The PTH-Vitamin D-FGF23 axis.

Authors:  Jenny E Blau; Michael T Collins
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

5.  Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.

Authors:  Mary D Ruppe; Patrick G Brosnan; Kit Sing Au; Phong X Tran; Barbara W Dominguez; Hope Northrup
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

Review 6.  Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?

Authors:  Michael P Whyte; S Deepak Amalnath; William H McAlister; Marc D McKee; Deborah J Veis; Margaret Huskey; Shenghui Duan; Vinieth N Bijanki; Suhas Alur; Steven Mumm
Journal:  Bone       Date:  2019-12-13       Impact factor: 4.398

7.  Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23.

Authors:  Yinshi Ren; Xianglong Han; Yan Jing; Baozhi Yuan; Huazhu Ke; Min Liu; Jian Q Feng
Journal:  Matrix Biol       Date:  2015-12-22       Impact factor: 11.583

Review 8.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

Review 9.  Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

Authors:  Jian Q Feng; Erica L Clinkenbeard; Baozhi Yuan; Kenneth E White; Marc K Drezner
Journal:  Bone       Date:  2013-02-09       Impact factor: 4.398

Review 10.  Fibroblast growth factor 23: state of the field and future directions.

Authors:  Nisan Bhattacharyya; William H Chong; Rachel I Gafni; Michael T Collins
Journal:  Trends Endocrinol Metab       Date:  2012-08-24       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.